483 KBI Biopharma Dec 2016

483 KBI Biopharma Dec 2016

Monica Commerford FDA, Marion Michaelis FDA$119.00 - Available Now

FDA investigators audited the KBI Biopharma - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 09 Dec 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Dec 2016
  • Location: Boulder, United States
  • FEI: 3011326133
Add To Cart